PennPET Explorer Scanner Evaluation
NCT04617912 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 268
Last updated 2026-02-12
Summary
Positron Emission Tomography (PET) is a procedure that uses a special type of machine to take pictures of the inside of the body after a radioactive drug is administered. The radioactive drug that is used for this study may be an FDA approved imaging drug or may be used as an investigational imaging drug as part of another study for which participants are taking part. PET using various radiotracers is useful for the diagnosis of various diseases, including cancer, brain diseases, infection, and heart or lung disease.
The purpose of this study is to test a research PET machine called the PennPET Explorer long-axial field-of-view scanner. This research PET machine can image a larger section of the body than the current clinical PET scanners, allowing most of the body to be imaged at one time. This scanner is still an investigational device and is being tested in this study to collect more information about how best to use this type of whole body scanner.
Conditions
- Healthy
- Cognitive Impairment
Interventions
- DEVICE
-
Long AFOV PennPET Explorer
A long-axial field-of-view (LAFOV) time-of-flight PET scanner, developed at the University of Pennsylvania, being tested for real-world applications.
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-11-12
- Primary Completion
- 2026-01-22
- Completion
- 2027-01-22
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
In-Room PET in Proton Radiation Therapy
NCT01228448 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors
NCT02978586 ·Status: COMPLETED
-
Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity
NCT04715750 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study
NCT01269593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Translational Development of Photon-counting CT Imaging
NCT03878134 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
NCT05160480 ·Status: ENROLLING_BY_INVITATION
-
Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer
NCT03100136 ·Status: COMPLETED ·Phase: PHASE1
-
Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT
NCT03846167 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
NCT03125629 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Application of the J-PET Scanner Prototype
NCT06242119 ·Status: RECRUITING
-
Enhancing SUV Accuracy of PET/MR for Clinical Trial Qualification
NCT03603925 ·Status: COMPLETED
-
Assessing Ultra-low Dose PET/CT and CT-less PET Using a Long Axial Field-of-view PET/CT System
NCT05496920 ·Status: COMPLETED ·Phase: NA
-
Exploratory Study Using a New Head-only PET Scanner
NCT04511546 ·Status: COMPLETED ·Phase: NA
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
Pembrolizumab-PET Imaging
NCT02760225 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Imaging With [18F]VM4-037
NCT00935142 ·Status: WITHDRAWN ·Phase: PHASE1
-
Assessment of Investigational Positron Emission Tomography and Post-Processing Procedures Performed as Add-ons to Standard of Care Imaging
NCT03490812 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)
NCT03423407 ·Status: TERMINATED
-
Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)
NCT02173964 ·Status: COMPLETED ·Phase: PHASE4
-
A Positron Emission Tomography (PET) Study to Investigate P2X7 Receptor Occupancy by JNJ-55308942 Using [18F]-JNJ-64413739
NCT03437590 ·Status: COMPLETED ·Phase: PHASE1
-
A PET Study in Healthy Volunteers
NCT01424449 ·Status: COMPLETED ·Phase: PHASE1
-
FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
NCT02055586 ·Status: COMPLETED
-
Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities
NCT04152928 ·Status: UNKNOWN ·Phase: NA
-
Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer
NCT01186601 ·Status: COMPLETED ·Phase: PHASE1
-
[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
NCT04263792 ·Status: RECRUITING ·Phase: PHASE1